Woodcliff Lake-based Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., announced the immediate appointment of Patrick Coyle as vice president and chief Financial officer (CFO). In this role, Coyle will have full oversight and responsibility for leading Eisai’s financial operations in the United States and Canada. He will also serve as a member of the company’s executive committee.
Coyle is a seasoned financial professional who has more than two decades of experience in financial planning and analysis, operations and strategy development from his tenure at several prominent healthcare companies. Before joining Eisai, he served as vice president, Financial Planning and Analysis at INSMED Inc. Previously, he held positions of increasing responsibility in the Finance departments at Novartis, Bayer HealthCare Pharmaceuticals, Sun Chemical and Computer Horizons Corporation.
“Patrick joins Eisai at an extraordinary time in our company’s evolution as we deepen our commitment and investments in oncology and neurology,” said Shaji Procida, president and chief operating officer at Eisai Inc. “As part of our executive team, his diverse financial background, strategic vision and proven leadership will be invaluable as we continue our relentless efforts to ensure we are breaking through to find innovative solutions and medicines to maximize the potential benefits for more patients.”
Coyle earned both a Master of Business Administration (MBA) degree in Business Management and a Bachelor of Science degree in Business Management and Accounting from The School of Business at Montclair State University. He completed the Finance Leadership Program at Harvard Business School in 2017.
To access more business news, visit NJB News Now.